Search results for " oligonucleotide array"
showing 3 items of 13 documents
La tecnologia del DNA-microarray per l'identificazione di specie microbiche su superfici e nell'aerosol di ambienti confinati
2009
La tecnologia del DNA microarray è utilizzata nei nostri laboratori per lo sviluppo di piattaforme multi-diagnostiche finalizzate alla identificazione di microrganismi. Il sistema è applicabile a campioni biologici prelevati in ambienti confinati, dove funghi e batteri rappresentano una delle componenti principali. Questi microrganismi, sono in grado di svilupparsi, in stretta relazione con determinati parametri come: i valori di temperatura e umidità relativa, le caratteristiche chimico fisiche dei materiali, e delle superfici, la tipologia di aerosol di questi ambienti. L’instaurarsi di consorzi microbici complessi e stabili oltre ad accelerare il degrado superficiale dei materiali, può c…
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
2013
Journal article TERT-locus SNPs and leukocyte telomere measures are reportedly associated with risks of multiple cancers. Using the Illumina custom genotyping array iCOGs, we analyzed ~480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. Leukocyte telomere measurements were also available for 53,724 participants. Most associations cluster into three independent peaks. The minor allele at the peak 1 SNP rs2736108 associates with longer telomeres (P = 5.8 × 10!-7), lower risks for estrogen receptor (ER)-negative (P = 1.0 × 10!-8) and BRCA1 mutation carrier (P = 1.1 × 10!-5) breast cancers and altered promot…
Proton-irradiated breast cells: molecular points of view
2019
Abstract Breast cancer (BC) is the most common cancer in women, highly heterogeneous at both the clinical and molecular level. Radiation therapy (RT) represents an efficient modality to treat localized tumor in BC care, although the choice of a unique treatment plan for all BC patients, including RT, may not be the best option. Technological advances in RT are evolving with the use of charged particle beams (i.e. protons) which, due to a more localized delivery of the radiation dose, reduce the dose administered to the heart compared with conventional RT. However, few data regarding proton-induced molecular changes are currently available. The aim of this study was to investigate and descri…